121 related articles for article (PubMed ID: 1901273)
1. Bernard-Soulier syndrome in two Swedish families: effect of DDAVP on bleeding time.
Waldenström E; Holmberg L; Axelsson U; Winqvist I; Nilsson IM
Eur J Haematol; 1991 Mar; 46(3):182-7. PubMed ID: 1901273
[TBL] [Abstract][Full Text] [Related]
2. [Utility of desmopressin in 4 cases of thrombocytopathies associated with giant platelets].
Martínez-Murillo C; Quintana-González S; Ambriz-Fernández R; Arzate-Hernández G; Gutiérrez-Romero M; Gaminio-Gómez E
Rev Invest Clin; 1997; 49(4):281-6. PubMed ID: 9707993
[TBL] [Abstract][Full Text] [Related]
3. DDAVP shortens the bleeding time in Bernard-Soulier syndrome.
Cuthbert RJ; Watson HH; Handa SI; Abbott I; Ludlam CA
Thromb Res; 1988 Mar; 49(6):649-50. PubMed ID: 3388316
[No Abstract] [Full Text] [Related]
4. A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) Ib and severely reduced amounts of GPIX and GPV.
Noris P; Arbustini E; Spedini P; Belletti S; Balduini CL
Br J Haematol; 1998 Dec; 103(4):1004-13. PubMed ID: 9886312
[TBL] [Abstract][Full Text] [Related]
5. DDAVP shortens bleeding time in Bernard-Soulier syndrome.
Kemahli S; Canatan D; Uysal Z; Akar N; Cin S; Arcasoy A
Thromb Haemost; 1994 May; 71(5):675. PubMed ID: 8091397
[No Abstract] [Full Text] [Related]
6. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.
Caen JP; Nurden AT; Jeanneau C; Michel H; Tobelem G; Levy-Toledano S; Sultan Y; Valensi F; Bernard J
J Lab Clin Med; 1976 Apr; 87(4):586-96. PubMed ID: 1083883
[TBL] [Abstract][Full Text] [Related]
7. Variation in surface platelet glycoprotein Ib expression in Bernard-Soulier syndrome.
Poulsen LO; Taaning E
Haemostasis; 1990; 20(3):155-61. PubMed ID: 2387554
[TBL] [Abstract][Full Text] [Related]
8. Bernard-Soulier syndrome: diagnosis by an ELISA method using monoclonal antibodies in 2 new unrelated patients.
De Marco L; Fabris F; Casonato A; Fabris P; Dal Ben MG; Barbato A; Girolami A
Acta Haematol; 1986; 75(4):203-8. PubMed ID: 3096050
[TBL] [Abstract][Full Text] [Related]
9. A three-base deletion removing a leucine residue in a leucine-rich repeat of platelet glycoprotein Ib alpha associated with a variant of Bernard-Soulier syndrome (Nancy I).
de la Salle C; Baas MJ; Lanza F; Schwartz A; Hanau D; Chevalier J; Gachet C; Briquel ME; Cazenave JP
Br J Haematol; 1995 Feb; 89(2):386-96. PubMed ID: 7873390
[TBL] [Abstract][Full Text] [Related]
10. Partial expression of GP Ib measured by flow cytometry in two patients with Bernard-Soulier syndrome.
Bunescu A; Lindahl T; Solum NO; Schulman S; Larsson A; Lundahl J; Egberg N
Thromb Res; 1994 Dec; 76(5):441-50. PubMed ID: 7900092
[TBL] [Abstract][Full Text] [Related]
11. Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex.
De Marco L; Mazzucato M; Fabris F; De Roia D; Coser P; Girolami A; Vicente V; Ruggeri ZM
J Clin Invest; 1990 Jul; 86(1):25-31. PubMed ID: 1694864
[TBL] [Abstract][Full Text] [Related]
12. Nonsense mutation in the glycoprotein Ib alpha coding sequence associated with Bernard-Soulier syndrome.
Ware J; Russell SR; Vicente V; Scharf RE; Tomer A; McMillan R; Ruggeri ZM
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):2026-30. PubMed ID: 2308962
[TBL] [Abstract][Full Text] [Related]
13. 1-Deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass.
Sloand EM; Alyono D; Klein HG; Chang P; Yu M; Lightfoot FG; Kessler C
Am J Hematol; 1994 Jul; 46(3):199-207. PubMed ID: 8192149
[TBL] [Abstract][Full Text] [Related]
14. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
[TBL] [Abstract][Full Text] [Related]
15. Genetic characterization of patients with Bernard-Soulier syndrome and their relatives from Southern Iran.
Afrasiabi A; Lecchi A; Artoni A; Karimi M; Ashouri E; Peyvandi F; Mannucci PM
Platelets; 2007 Sep; 18(6):409-13. PubMed ID: 17763149
[TBL] [Abstract][Full Text] [Related]
16. Evidence that DDAVP transiently improves hemostasis in Bernard-Soulier syndrome independent of von Willebrand-factor.
Greinacher A; Pötzsch B; Kiefel V; White JG; Müller-Berghaus G; Mueller-Eckhardt C
Ann Hematol; 1993 Sep; 67(3):149-50. PubMed ID: 8373905
[No Abstract] [Full Text] [Related]
17. DDAVP in Bernard-Soulier syndrome.
Mant MJ
Thromb Res; 1988 Oct; 52(1):77-8. PubMed ID: 3201400
[No Abstract] [Full Text] [Related]
18. IIB von Willebrand's disease: pathogenetic and therapeutic studies.
Kyrle PA; Niessner H; Dent J; Panzer S; Brenner B; Zimmerman TS; Lechner K
Br J Haematol; 1988 May; 69(1):55-9. PubMed ID: 3132965
[TBL] [Abstract][Full Text] [Related]
19. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
20. Is the pro-adhesive activity of plasma von Willebrand factor counteracted by a physiological inhibitor of platelet adhesiveness?
Porta M; Cagliero E; Kohner EM
Clin Sci (Lond); 1982 Feb; 62(2):239-42. PubMed ID: 6797774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
